Article Information
History
- April 12, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Youyi Fong1,2,
- Adrian B. McDermott3,
- David Benkeser4,
- Sanne Roels5,
- Daniel J. Stieh6,
- An Vandebosch5,
- Mathieu Le Gars6,
- Griet A. Van Roey6,
- Christopher R. Houchens7,
- Karen Martins7,
- Lakshmi Jayashankar7,
- Flora Castellino7,
- Obrimpong Amoa-Awua3,
- Manjula Basappa3,
- Britta Flach3,
- Bob C. Lin3,
- Christopher Moore3,
- Mursal Naisan3,
- Muhammed Naqvi3,
- Sandeep Narpala3,
- Sarah O’Connell3,
- Allen Mueller3,
- Leo Serebryannyy3,
- Mike Castro3,
- Jennifer Wang3,
- Christos J. Petropoulos8,
- Alex Luedtke9,
- Ollivier Hyrien1,2,
- Yiwen Lu1,
- Chenchen Yu1,
- Bhavesh Borate1,
- Lars W. P. van der Laan1,9,
- Nima S. Hejazi1,10,
- Avi Kenny11,
- Marco Carone11,
- Daniel N. Wolfe7,
- Jerald Sadoff6,
- Glenda E. Gray12,13,
- Beatriz Grinsztejn14,
- Paul A. Goepfert15,
- Susan J. Little16,
- Leonardo Paiva de Sousa14,
- Rebone Maboa17,
- April K. Randhawa1,
- Michele P. Andrasik1,
- Jenny Hendriks6,
- Carla Truyers5,
- Frank Struyf5,
- Hanneke Schuitemaker6,
- Macaya Douoguih6,
- James G. Kublin1,
- Lawrence Corey1,18,
- Kathleen M. Neuzil19,
- Lindsay N. Carpp1,
- Dean Follmann20,
- Peter B. Gilbert1,2,11,#,*,
- Richard A. Koup3,#,
- Ruben O. Donis7,#,
- the Immune Assays Team§,
- the Janssen Team§,
- the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team§,
- the United States Government (USG)/CoVPN Biostatistics Team§
- 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
- 2Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
- 3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
- 4Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA
- 5Janssen R&D, a division of Janssen Pharmaceutica NV, Beerse, Belgium
- 6Janssen Vaccines and Prevention, Leiden, the Netherlands
- 7Biomedical Advanced Research and Development Authority, Washington, DC, USA
- 8LabCorp-Monogram Biosciences, South San Francisco, CA, USA
- 9Department of Statistics, University of Washington, Seattle, WA, USA
- 10Division of Biostatistics, School of Public Health, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA
- 11Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA
- 12Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 13South African Medical Research Council, Cape Town, South Africa
- 14Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil
- 15Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
- 16Division of Infectious Diseases, University of California San Diego, La Jolla, CA, USA
- 17Ndlovu Elandsdoorn Site, Limpopo, Dennilton, South Africa
- 18Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
- 19Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA
- 20Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
- ↵*Corresponding author. pgilbert{at}fredhutch.org
↵# These authors contributed equally to this work.